» Articles » PMID: 1652557

Topology of Outer Membrane Porins in Pathogenic Neisseria Spp

Overview
Journal Infect Immun
Date 1991 Sep 1
PMID 1652557
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

In Escherichia coli, membrane-spanning amphipathic beta-sheet structures are characteristic of many outer membrane proteins. By applying the principles that have been recognized for them to the four classes of neisserial porins, we have constructed a model for the topology of the porins within the outer membrane. This model predicts eight surface-exposed loops, both in the meningococcal class 1 and 2 proteins and in the gonococcal PIA and PIB proteins. The transmembrane sequences are highly conserved among these porins and are able to form an amphipathic beta-sheet structure. The surface-exposed hydrophilic loops show extensive variation in both length and sequence. Experimental evidence in support of this model has been obtained by using antisera against synthetic peptides which correspond to surface-exposed loops in class 1 and 2 proteins. Thus, binding to the cell surface was observed with antibodies against loops 1, 4, and 5 of class 1 and loops 1 and 5 of class 2. In class 1, these loops are the longest ones and show the highest sequence diversity among strains of different subtypes. Mapping of epitopes recognized by monoclonal antibodies with bactericidal activity has also provided strong support for the model. The epitopes are located in loops 1 and 4 of class 1 protein, loop 5 of PIB, and loop 6 of PIA. A nonbactericidal antibody that binds only weakly to whole cells was shown to recognize loop 3 of PIB. These results suggest that the longest loops are immunodominant, provide the binding sites for bactericidal antibodies, and display the greatest variation among different strains.

Citing Articles

Fluorescent Labeling of Outer Membrane Proteins Using the SpyCatcher-SpyTag System.

Duodu R, Linke D, Leo J Methods Mol Biol. 2024; 2778:53-63.

PMID: 38478271 DOI: 10.1007/978-1-0716-3734-0_4.


Molecular characterisation of associated with disseminated gonococcal infections in Queensland, Australia: a retrospective surveillance study.

Guglielmino C, Sandhu S, Lau C, Buckely C, Trembizki E, Whiley D BMJ Open. 2022; 12(8):e061040.

PMID: 35918119 PMC: 9351343. DOI: 10.1136/bmjopen-2022-061040.


Viral vectors expressing group B meningococcal outer membrane proteins induce strong antibody responses but fail to induce functional bactericidal activity.

Marsay L, Dold C, Paterson G, Yamaguchi Y, Derrick J, Chan H J Infect. 2022; 84(5):658-667.

PMID: 35245584 PMC: 7616632. DOI: 10.1016/j.jinf.2022.02.032.


Recent advances in understanding and combatting : a genomic perspective.

Harrison O, Maiden M Fac Rev. 2021; 10:65.

PMID: 34557869 PMC: 8442004. DOI: 10.12703/r/10-65.


Progress Toward a Gonococcal Vaccine: The Way Forward.

Russell M, Jerse A, Gray-Owen S Front Immunol. 2019; 10:2417.

PMID: 31681305 PMC: 6803597. DOI: 10.3389/fimmu.2019.02417.


References
1.
Knapp J, Tam M, Nowinski R, Holmes K, Sandstrom E . Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis. 1984; 150(1):44-8. DOI: 10.1093/infdis/150.1.44. View

2.
Nakane P, Kawaoi A . Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974; 22(12):1084-91. DOI: 10.1177/22.12.1084. View

3.
Saukkonen K, Abdillahi H, Poolman J, Leinonen M . Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb Pathog. 1987; 3(4):261-7. DOI: 10.1016/0882-4010(87)90059-3. View

4.
Higgins D, Sharp P . CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene. 1988; 73(1):237-44. DOI: 10.1016/0378-1119(88)90330-7. View

5.
Saukkonen K, Leinonen M, Abdillahi H, Poolman J . Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine. 1989; 7(4):325-8. DOI: 10.1016/0264-410x(89)90194-1. View